VEGFD and neoplasm: In conclusion, our results indicated that YL529 significantly inhibited the tumor-associated lymphangiogenesis and metastasis induced by VEGF-D in the established VEGF-D over-expressing Lewis lung carcinoma model (Fig. 7).